XML 77 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Warrants (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
May 15, 2023
Other disclosures      
Purchaseable stock 19,795,053 19,624,860  
Compensation expense $ 220,000 $ 720,000  
Halston License      
Other disclosures      
Contra-revenue $ 30,000.00    
Warrants      
Number of Other than Options      
Outstanding and exercisable, beginning balance (in shares) 116,065    
Granted (in shares) 1,000,000    
Outstanding, ending balance (in shares) 1,116,065 116,065  
Exercisable (in shares) 116,065    
Weighted Average Exercise Price      
Outstanding and exercisable, beginning balance (in dollars per share) $ 3.15    
Granted (in dollars per share) 1.50    
Outstanding, ending balance (in dollars per share) 1.67 $ 3.15  
Exercisable, ending balance (in dollars per share) $ 3.15    
Weighted Average Remaining Contractual Life (in Years), Outstanding 8 years 6 months 16 days 1 year 7 months 27 days  
Weighted Average Contractual Life (in Years), Exercisable 7 months 27 days    
Other disclosures      
Compensation expense $ 0 $ 0  
Warrants | Halston License      
Other disclosures      
Purchaseable stock     1,000,000
Warrants | Five year expiration      
Stockholders' Equity      
Expiration period 5 years    
Warrants | Seven year expiration      
Stockholders' Equity      
Expiration period 7 years    
Warrants | Ten year expiration      
Stockholders' Equity      
Expiration period 10 years